Levetiracetam Liver Injury: A Benign Antiepileptic Agent?-Reference-Cited by-同舟云学术

Levetiracetam Liver Injury: A Benign Antiepileptic Agent?

Published:2023-03 Issue:3 Volume:10 Page:e01003
ISSN:2326-3253
Container-title:ACG Case Reports Journal
language:en
Short-container-title:ACG Case Rep J

Author:

Hegazy Yassmin¹²,Axley Page¹³,Lee Goo¹⁴,Gray Meagan¹³

Affiliation:

1. Department of Medicine, University of Alabama Birmingham Hospital, Birmingham, AL

2. Department of Internal Medicine, University of Alabama Birmingham Hospital, Birmingham, AL

3. Department of Gastroenterology and Hepatology, University of Alabama Birmingham Hospital, Birmingham, AL

4. Department of Pathology, University of Alabama Birmingham Hospital, Birmingham, AL

Abstract

ABSTRACT Levetiracetam is a commonly prescribed antiepileptic agent and has rarely been linked to hepatotoxicity. This case describes a patient with drug-induced autoimmune hepatitis secondary to levetiracetam.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference13 articles.

1. A rare case of drug-induced liver injury caused by levetiracetam;Kawaguchi;Asian J Neurosurg.,2019

2. Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease;Castiella;World J Hepatol.,2014

3. Drug-induced autoimmune-like hepatitis;Czaja;Dig Dis Sci.,2011

4. Case report: Levetiracetam causing acute liver failure complicating post-operative management in a neurosurgical patient;Jayashankar;F1000Res.,2019

5. Pathology of autoimmune hepatitis;Covelli;Pathologica.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levetiracetam;Reactions Weekly;2023-05-13